The next frontier in cardiac disease management

Cardiosense combines multimodal wearable technology with AI to detect early signs of cardiac disease, guide personalized therapy, and improve patient outcomes.

Unlocking new insights from physiological signals

Built on nearly two decades of clinical and engineering research, the Cardiosense platform analyzes key physiological signals to detect early, measurable changes in cardiovascular function—enabling timely intervention before symptoms appear. Validated through peer-reviewed published research, our technology ensures consistent, reliable performance across diverse patient populations and care settings.

The CardioTag device has been cleared to market as a class II medical device.

AI-powered clinical solutions built for proactive, precision cardiac care

CardioTag™ Sensor

Medical-grade, multimodal wearable device designed to noninvasive measure seismocardiogram (SCG), photoplethysmogram (PPG), and electrocardiogram (ECG) signals, enabling comprehensive cardiac assessments from hospital to home.

Clinical AI

Deep learning algorithms translate signals from the CardioTag sensor and other 3rd-party devices into digital biomarkers predictive of heart failure, hemodynamic instability, and other forms of cardiac dysfunction—enabling smarter, more personalized clinical care.

Workflow Platform

Integrated software solutions that aggregate CardioTag and AI data into actionable clinical insights, designed specifically to streamline workflows and seamlessly integrate into diverse care environments.